Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Application of Strategic Transport Model and Google Maps to Develop Better Clot Retrieval Stroke Service.

Tajaddini A, Phan TG, Beare R, Ma H, Srikanth V, Currie G, Vu HL.

Front Neurol. 2019 Jun 28;10:692. doi: 10.3389/fneur.2019.00692. eCollection 2019.

2.

Assessment of waste characteristics and their impact on GIS vehicle collection route optimization using ANN waste forecasts.

Vu HL, Bolingbroke D, Ng KTW, Fallah B.

Waste Manag. 2019 Apr 1;88:118-130. doi: 10.1016/j.wasman.2019.03.037. Epub 2019 Mar 22.

PMID:
31079624
3.

Time-lagged effects of weekly climatic and socio-economic factors on ANN municipal yard waste prediction models.

Vu HL, Ng KTW, Bolingbroke D.

Waste Manag. 2019 Feb 1;84:129-140. doi: 10.1016/j.wasman.2018.11.038. Epub 2018 Nov 27.

PMID:
30691884
4.

Visualization and analysis of mapping knowledge domain of road safety studies.

Zou X, Yue WL, Vu HL.

Accid Anal Prev. 2018 Sep;118:131-145. doi: 10.1016/j.aap.2018.06.010. Epub 2018 Jun 27.

PMID:
29958121
5.

Use of seasonal parameters and their effects on FOD landfill gas modeling.

Bruce N, Ng KTW, Vu HL.

Environ Monit Assess. 2018 Apr 18;190(5):291. doi: 10.1007/s10661-018-6663-x.

PMID:
29667037
6.

Acne Scarring-Pathogenesis, Evaluation, and Treatment Options.

Connolly D, Vu HL, Mariwalla K, Saedi N.

J Clin Aesthet Dermatol. 2017 Sep;10(9):12-23. Epub 2017 Sep 1. Review.

7.

Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.

Pattnaik A, Palermo N, Sahoo BR, Yuan Z, Hu D, Annamalai AS, Vu HLX, Correas I, Prathipati PK, Destache CJ, Li Q, Osorio FA, Pattnaik AK, Xiang SH.

Antiviral Res. 2018 Mar;151:78-86. doi: 10.1016/j.antiviral.2017.12.016. Epub 2017 Dec 21.

PMID:
29274845
8.

Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus.

Sun H, Workman A, Osorio FA, Steffen D, Vu HLX.

Vaccine. 2018 Jan 2;36(1):66-73. doi: 10.1016/j.vaccine.2017.11.028. Epub 2017 Nov 22.

PMID:
29174314
9.

Zika Virus Encoding Nonglycosylated Envelope Protein Is Attenuated and Defective in Neuroinvasion.

Annamalai AS, Pattnaik A, Sahoo BR, Muthukrishnan E, Natarajan SK, Steffen D, Vu HLX, Delhon G, Osorio FA, Petro TM, Xiang SH, Pattnaik AK.

J Virol. 2017 Nov 14;91(23). pii: e01348-17. doi: 10.1128/JVI.01348-17. Print 2017 Dec 1.

10.

Optimization of first order decay gas generation model parameters for landfills located in cold semi-arid climates.

Vu HL, Ng KTW, Richter A.

Waste Manag. 2017 Nov;69:315-324. doi: 10.1016/j.wasman.2017.08.028. Epub 2017 Aug 18.

PMID:
28823700
11.

Relative contribution of porcine reproductive and respiratory syndrome virus open reading frames 2-4 to the induction of protective immunity.

Kimpston-Burkgren K, Correas I, Osorio FA, Steffen D, Pattnaik AK, Fang Y, Vu HLX.

Vaccine. 2017 Aug 3;35(34):4408-4413. doi: 10.1016/j.vaccine.2017.06.061. Epub 2017 Jul 6.

PMID:
28689650
12.

Cross reactivity of immune responses to porcine reproductive and respiratory syndrome virus infection.

Correas I, Osorio FA, Steffen D, Pattnaik AK, Vu HLX.

Vaccine. 2017 Feb 1;35(5):782-788. doi: 10.1016/j.vaccine.2016.12.040. Epub 2017 Jan 3.

PMID:
28062126
13.

Identification of viral genes associated with the interferon-inducing phenotype of a synthetic porcine reproductive and respiratory syndrome virus strain.

Sun H, Pattnaik AK, Osorio FA, Vu HLX.

Virology. 2016 Dec;499:313-321. doi: 10.1016/j.virol.2016.09.018. Epub 2016 Oct 11.

14.

Strategies to broaden the cross-protective efficacy of vaccines against porcine reproductive and respiratory syndrome virus.

Vu HLX, Pattnaik AK, Osorio FA.

Vet Microbiol. 2017 Jul;206:29-34. doi: 10.1016/j.vetmic.2016.09.014. Epub 2016 Sep 21. Review.

PMID:
27692670
15.

Complete Genome Sequence of Highly Virulent Porcine Reproductive and Respiratory Syndrome Virus Variants That Recently Emerged in the United States.

Workman AM, Smith TP, Osorio FA, Vu HL.

Genome Announc. 2016 Aug 4;4(4). pii: e00772-16. doi: 10.1128/genomeA.00772-16.

16.

Characterization of serum antibodies from women immunized with Gardasil: A study of HPV-18 infection of primary human keratinocytes.

Wang HK, Wei Q, Moldoveanu Z, Huh WK, Vu HL, Broker TR, Mestecky J, Chow LT.

Vaccine. 2016 Jun 8;34(27):3171-3177. doi: 10.1016/j.vaccine.2016.04.038. Epub 2016 Apr 23.

17.

Targeting mutant NRAS signaling pathways in melanoma.

Vu HL, Aplin AE.

Pharmacol Res. 2016 May;107:111-116. doi: 10.1016/j.phrs.2016.03.007. Epub 2016 Mar 15. Review.

18.

MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma.

Vu HL, Rosenbaum S, Capparelli C, Purwin TJ, Davies MA, Berger AC, Aplin AE.

J Invest Dermatol. 2016 Feb;136(2):453-463. doi: 10.1016/j.jid.2015.11.012. Epub 2015 Nov 20.

19.

A Synthetic Porcine Reproductive and Respiratory Syndrome Virus Strain Confers Unprecedented Levels of Heterologous Protection.

Vu HL, Ma F, Laegreid WW, Pattnaik AK, Steffen D, Doster AR, Osorio FA.

J Virol. 2015 Dec;89(23):12070-83. doi: 10.1128/JVI.01657-15. Epub 2015 Sep 23.

20.

RAC1 P29S regulates PD-L1 expression in melanoma.

Vu HL, Rosenbaum S, Purwin TJ, Davies MA, Aplin AE.

Pigment Cell Melanoma Res. 2015 Sep;28(5):590-8. doi: 10.1111/pcmr.12392.

21.

Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma.

Vu HL, Aplin AE.

Mol Cancer Res. 2014 Oct;12(10):1509-19. doi: 10.1158/1541-7786.MCR-14-0204. Epub 2014 Jun 24.

22.

In vitro high throughput screening, what next? Lessons from the screening for aurora kinase inhibitors.

Hoang TM, Vu HL, Le LT, Nguyen CH, Molla A.

Biology (Basel). 2014 Feb 27;3(1):167-75. doi: 10.3390/biology3010167.

23.

Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus.

Vu HL, Kwon B, de Lima M, Pattnaik AK, Osorio FA.

Vaccine. 2013 Sep 13;31(40):4330-7. doi: 10.1016/j.vaccine.2013.07.020. Epub 2013 Jul 23.

24.

Basal aurora kinase B activity is sufficient for histone H3 phosphorylation in prophase.

Le LT, Vu HL, Nguyen CH, Molla A.

Biol Open. 2013 Feb 14;2(4):379-86. doi: 10.1242/bio.20133079. Print 2013 Apr 15.

25.

Hydrosoluble benzo[e]pyridoindolones as potent inhibitors of aurora kinases.

Le LT, Vu HL, Naud-Martin D, Bombled M, Nguyen CH, Molla A.

ChemMedChem. 2013 Feb;8(2):289-96. doi: 10.1002/cmdc.201200479. Epub 2012 Dec 28.

PMID:
23281044
26.

Identification of amino acid residues important for anti-IFN activity of porcine reproductive and respiratory syndrome virus non-structural protein 1.

Beura LK, Subramaniam S, Vu HL, Kwon B, Pattnaik AK, Osorio FA.

Virology. 2012 Nov 25;433(2):431-9. doi: 10.1016/j.virol.2012.08.034. Epub 2012 Sep 18.

27.

Phase-matched generation of highly coherent radiation in water window region.

Dao LV, Hall C, Vu HL, Dinh KB, Balaur E, Hannaford P, Smith TA.

Appl Opt. 2012 Jun 20;51(18):4240-5. doi: 10.1364/AO.51.004240.

PMID:
22722304
28.

The Yin-Yang of RAF inhibitors.

Vu HL, Aplin AE.

Pigment Cell Melanoma Res. 2012 Mar;25(2):127-8. doi: 10.1111/j.1755-148X.2011.00947.x. Epub 2012 Jan 19. No abstract available.

PMID:
22409366
29.

Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy.

Fu S, Rivera M, Ko EC, Sikora AG, Chen CT, Vu HL, Cannan D, Eisenstein S, Rosenstein BS, Aguirre-Ghiso J, Chen SH, Kao J.

J Cell Sci Ther. 2011 Oct 13;1(2). pii: S1-002.

30.

[Survivin reads the mitotic histone code].

Vu HL, Molla A.

Med Sci (Paris). 2011 Mar;27(3):241-3. doi: 10.1051/medsci/2011273241. Epub 2011 Mar 30. French. No abstract available.

31.

Immune evasion of porcine reproductive and respiratory syndrome virus through glycan shielding involves both glycoprotein 5 as well as glycoprotein 3.

Vu HL, Kwon B, Yoon KJ, Laegreid WW, Pattnaik AK, Osorio FA.

J Virol. 2011 Jun;85(11):5555-64. doi: 10.1128/JVI.00189-11. Epub 2011 Mar 16.

32.

Glycosylation of minor envelope glycoproteins of porcine reproductive and respiratory syndrome virus in infectious virus recovery, receptor interaction, and immune response.

Das PB, Vu HL, Dinh PX, Cooney JL, Kwon B, Osorio FA, Pattnaik AK.

Virology. 2011 Feb 20;410(2):385-94. doi: 10.1016/j.virol.2010.12.002. Epub 2010 Dec 30.

33.

Aurora B kinase, an immobile passenger!

Delacour-Larose M, Vu HL, Molla A.

Cell Cycle. 2009 Nov 1;8(21):3608-9. Epub 2009 Nov 27. No abstract available.

34.

HPV-induced oropharyngeal cancer, immune response and response to therapy.

Vu HL, Sikora AG, Fu S, Kao J.

Cancer Lett. 2010 Feb 28;288(2):149-55. doi: 10.1016/j.canlet.2009.06.026. Epub 2009 Jul 22. Review.

PMID:
19628331
35.

The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.

Kao J, Vu HL, Genden EM, Mocherla B, Park EE, Packer S, Som PM, Kostakoglu L.

Cancer. 2009 Oct 1;115(19):4586-94. doi: 10.1002/cncr.24493.

36.

Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response.

Kao J, Packer S, Vu HL, Schwartz ME, Sung MW, Stock RG, Lo YC, Huang D, Chen SH, Cesaretti JA.

Cancer. 2009 Aug 1;115(15):3571-80. doi: 10.1002/cncr.24412. Erratum in: Cancer. 2011 Jun 15;117(12):2826.

37.

IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.

Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, Alarcón GS, Kimberly RP, Tomino Y, Mestecky J, Novak J.

J Clin Invest. 2008 Feb;118(2):629-39. doi: 10.1172/JCI33189.

38.

Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire.

Nguyen HH, Zemlin M, Ivanov II, Andrasi J, Zemlin C, Vu HL, Schelonka R, Schroeder HW Jr, Mestecky J.

J Virol. 2007 Sep;81(17):9331-8. Epub 2007 Jun 13.

39.

Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells.

Raska M, Moldoveanu Z, Suzuki H, Brown R, Kulhavy R, Andrasi J, Hall S, Vu HL, Carlsson F, Lindahl G, Tomana M, Julian BA, Wyatt RJ, Mestecky J, Novak J.

J Mol Biol. 2007 May 25;369(1):69-78. Epub 2007 Mar 12.

40.

Mucosal IL-8 and TGF-beta recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells.

Smythies LE, Maheshwari A, Clements R, Eckhoff D, Novak L, Vu HL, Mosteller-Barnum LM, Sellers M, Smith PD.

J Leukoc Biol. 2006 Sep;80(3):492-9. Epub 2006 Jul 20.

PMID:
16793909
41.
42.

Oral and nasal sensitization promote distinct immune responses and lung reactivity in a mouse model of peanut allergy.

Fischer R, McGhee JR, Vu HL, Atkinson TP, Jackson RJ, Tomé D, Boyaka PN.

Am J Pathol. 2005 Dec;167(6):1621-30.

43.

Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract.

van Ginkel FW, Jackson RJ, Yoshino N, Hagiwara Y, Metzger DJ, Connell TD, Vu HL, Martin M, Fujihashi K, McGhee JR.

Infect Immun. 2005 Oct;73(10):6892-902.

44.

Immune responses to human papillomavirus in genital tract of women with cervical cancer.

Nguyen HH, Broker TR, Chow LT, Alvarez RD, Vu HL, Andrasi J, Brewer LR, Jin G, Mestecky J.

Gynecol Oncol. 2005 Feb;96(2):452-61.

PMID:
15661235
45.

Interactions of human mesangial cells with IgA and IgA-containing immune complexes.

Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M.

Kidney Int. 2002 Aug;62(2):465-75.

46.

The timing of physiologic closure of the metopic suture: a review of 159 patients using reconstructed 3D CT scans of the craniofacial region.

Vu HL, Panchal J, Parker EE, Levine NS, Francel P.

J Craniofac Surg. 2001 Nov;12(6):527-32.

PMID:
11711818
47.

Mechanisms of immune tolerance to food antigens in humans.

Zivny JH, Moldoveanu Z, Vu HL, Russell MW, Mestecky J, Elson CO.

Clin Immunol. 2001 Nov;101(2):158-68.

PMID:
11683575
48.
49.

Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes.

Nguyen HH, van Ginkel FW, Vu HL, McGhee JR, Mestecky J.

J Infect Dis. 2001 Feb 1;183(3):368-76. Epub 2000 Dec 20.

PMID:
11133367
50.

Supplemental Content

Support Center